Detalles de la búsqueda
1.
Comparative safety and effectiveness of TNF inhibitors, IL6 inhibitors and methotrexate for the treatment of immune checkpoint inhibitor-associated arthritis.
Ann Rheum Dis
; 82(7): 920-926, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37019614
2.
Safety of recombinant zoster vaccine: a retrospective study of 622 rheumatology patients.
Rheumatology (Oxford)
; 60(11): 5149-5157, 2021 11 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33560302
3.
National Psoriasis Foundation COVID-19 Task Force guidance for management of psoriatic disease during the pandemic: Version 2-Advances in psoriatic disease management, COVID-19 vaccines, and COVID-19 treatments.
J Am Acad Dermatol
; 84(5): 1254-1268, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33422626
4.
Tocilizumab therapy in 5 solid and composite tissue transplant recipients with early ARDS due to SARS-CoV-2.
Am J Transplant
; 20(11): 3191-3197, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32476261
5.
COVID-19: a primer for the rheumatologist: management of patients and care settings.
Curr Opin Rheumatol
; 32(5): 429-433, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32744823
6.
The immunopathogenesis of rheumatic immune adverse events from checkpoint inhibitors: prospects for targeted therapy.
Curr Opin Rheumatol
; 32(2): 175-183, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31922970
7.
National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease During the Pandemic: Version 1.
J Am Acad Dermatol
; 83(6): 1704-1716, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32891785
8.
The Future of COVID-19 for Patients With Immune-Mediated Inflammatory Diseases: Who Is at Risk?
J Rheumatol
; 51(3): 221-223, 2024 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38224980
9.
SARS CoV-2 infection among patients using immunomodulatory therapies.
Ann Rheum Dis
; 80(2): 269-271, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32759259
10.
Editorial: Reflections on rheumatological aspects of COVID-19.
Curr Opin Rheumatol
; 32(5): 427-428, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32675718
11.
Addressing immune-related adverse events of cancer immunotherapy: how prepared are rheumatologists?
Ann Rheum Dis
; 78(6): 860-862, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30659050
12.
A scoping review of vasculitis as an immune-related adverse event from checkpoint inhibitor therapy of cancer: Unraveling the complexities at the intersection of immunology and vascular pathology.
Semin Arthritis Rheum
; 66: 152440, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38579593
13.
Imaging in Rheumatic Immune-related Adverse Events.
Rheum Dis Clin North Am
; 50(2): 313-323, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38670729
14.
Mechanistic insights into bone remodelling dysregulation by human viral pathogens.
Nat Microbiol
; 9(2): 322-335, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38316931
15.
Schnitzler syndrome.
BMJ Case Rep
; 16(5)2023 May 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-37202108
16.
Risk factors for severe COVID-19 among patients with systemic lupus erythematosus: a real-world analysis of a large representative US administrative claims database, 2020-2021.
RMD Open
; 9(3)2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37591618
17.
Immune checkpoint inhibitor induced myocarditis, myasthenia gravis, and myositis: A single-center case series.
Cancer Med
; 12(3): 2281-2289, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36128926
18.
Learning Needs of Patients with Cancer and a Pre-Existing Autoimmune Disease Who Are Candidates to Receive Immune Checkpoint Inhibitors.
Cancers (Basel)
; 15(15)2023 Aug 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37568819
19.
Physician Views on the Provision of Information on Immune Checkpoint Inhibitor Therapy to Patients with Cancer and Pre-Existing Autoimmune Disease: A Qualitative Study.
Cancers (Basel)
; 15(10)2023 May 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37345026
20.
American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 5.
Arthritis Rheumatol
; 75(1): E1-E16, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36345691